21 CFR Part 11 applies to electronic records required by FDA predicate rules and to electronic signatures used in place of handwritten signatures.
Key control areas include:

21 CFR Part 11 applies when a CMMS is used to create, modify, maintain, archive, retrieve, or transmit electronic records that are required by FDA predicate rules, or when electronic signatures are used in place of handwritten signatures.
For maintenance, calibration, and validation systems, this may include:
Part 11 software should support the technical controls needed to maintain trustworthy electronic records and electronic signatures. The regulated organization remains responsible for defining intended use, validating the system, governing access, establishing procedures, training users, and managing record retention.
| Control | What the software must support | Evidence to request | Operating responsibility |
|---|---|---|---|
| Validated intended use | Consistent operation for defined regulated functions | Specifications, test evidence, and validation support documentation | Define intended use and perform appropriate validation |
| Access control | Unique users, authentication, permissions, and restricted functions | Security model, role definitions, and authentication behavior | Approve users, assign roles, and periodically review access |
| Audit trails | Secure, computer-generated, time-stamped history of applicable record changes | Audit-trail examples, configuration information, and test results | Define review expectations and investigate significant events |
| Record protection and retrieval | Accurate records, retention, protection, readable retrieval, and copies | Backup, recovery, export, retention, and retrieval information | Establish retention periods and backup/recovery procedures |
| Authority checks | Restrict applicable actions to authorized individuals | Permission matrix, workflow behavior, and authorization controls | Define authority levels and maintain user governance |
| Electronic signatures | Controlled signature execution and permanent linkage to the associated record | Signature workflow, authentication behavior, and signature examples | Verify identities, establish procedures, and manage credentials |
Where applicable, audit trails must be secure, computer-generated, time-stamped, attributable, retained for the required period, and available for review.
Regulatory requirement
Part 11 requires secure, computer-generated, time-stamped audit trails for applicable record creation and modification activities.
Implementation guidance
The operating company should define which audit-trail events require review, who performs the review, how often it occurs, and how unusual activity is investigated.
Electronic records must remain accurate, complete, protected, and available throughout the required retention period.
A buyer should request enough information to understand how the software works, evaluate whether it fits the intended use, and determine what validation work will still be required.
Vendor documentation can reduce validation effort, but the regulated organization remains responsible for determining whether the software is suitable and validated for its actual intended use.
The FDA does not certify or approve software products. Vendors provide systems designed to support regulatory requirements, but validation and compliance remain the responsibility of the regulated company.
General maintenance tools may lack audit trails, access controls, or validation documentation needed in regulated environments.
Highly configurable enterprise systems often increase validation scope and administrative burden without improving documentation integrity.
21 CFR Part 11 compliance software refers to systems designed to support FDA requirements for electronic records and electronic signatures in regulated environments.
For pharmaceutical, biotech, medical device, and nutraceutical companies, maintenance, calibration, and validation records are often considered GMP records. When stored electronically, these records must meet expectations for:
No. Part 11 does not independently require electronic signatures. When an applicable FDA regulation requires a signature and an organization uses an electronic signature, Part 11 establishes requirements for the associated electronic record and signature.
No. Part 11 generally applies when records required by an FDA regulation are maintained electronically, or when electronic signatures are used in place of required handwritten signatures. Applicability depends on the record, its intended use, and the underlying regulatory requirement.
No software product makes an organization compliant by itself. GxPReady includes technical controls designed to support Part 11 compliance, but compliance also depends on system configuration, validation, company procedures, user administration, training, and how the system is used. The GxPReady system development, turnover package and process are designed to minimize the time to compliance.
GxPReady includes a structured validation package that supports customer validation activities. Because the application is standardized and requires minimal configuration, validation is less time and resource intensive than with heavily customized enterprise systems.
GxPReady supports role-based access control, audit trails, electronic signatures, and electronic records designed to support 21 CFR Part 11 requirements. Appropriate procedures, user administration, training, and validation are also required and supported as part of the turnover process.
Yes. GxPReady maintains audit-trail information for applicable regulated records to support traceability and review of record changes. Audit trails should be reviewed and managed according to company procedures and the risk associated with the records.
Customers should define the system’s intended use, establish user roles and access, complete the required validation activities, train users, and implement appropriate procedures for system administration, electronic signatures, audit-trail review, record retention, and change control. This process is streamlined by our approach to the system design, development, documentation, and turnover process.